rs16059

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001127222.2(CACNA1A):​c.7431C>T​(p.Tyr2477Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00841 in 1,535,954 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0074 ( 11 hom., cov: 31)
Exomes 𝑓: 0.0085 ( 103 hom. )

Consequence

CACNA1A
NM_001127222.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.150

Publications

2 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 19-13207403-G-A is Benign according to our data. Variant chr19-13207403-G-A is described in ClinVar as [Benign]. Clinvar id is 257513.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.15 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00737 (1118/151678) while in subpopulation AMR AF = 0.0202 (308/15244). AF 95% confidence interval is 0.0183. There are 11 homozygotes in GnomAd4. There are 580 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 1118 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.7431C>T p.Tyr2477Tyr synonymous_variant Exon 47 of 47 ENST00000360228.11 NP_001120694.1 O00555-8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.7431C>T p.Tyr2477Tyr synonymous_variant Exon 47 of 47 1 NM_001127222.2 ENSP00000353362.5 O00555-8
CACNA1AENST00000638029.1 linkc.7449C>T p.Tyr2483Tyr synonymous_variant Exon 48 of 48 5 ENSP00000489829.1 A0A087WW63
CACNA1AENST00000573710.7 linkc.7437C>T p.Tyr2479Tyr synonymous_variant Exon 47 of 47 5 ENSP00000460092.3 A0A1C7CYY9
CACNA1AENST00000635727.1 linkc.7434C>T p.Tyr2478Tyr synonymous_variant Exon 47 of 47 5 ENSP00000490001.1 A0A1B0GU81
CACNA1AENST00000637769.1 linkc.7434C>T p.Tyr2478Tyr synonymous_variant Exon 47 of 47 1 ENSP00000489778.1 A0A1B0GTN7
CACNA1AENST00000636012.1 linkc.7398C>T p.Tyr2466Tyr synonymous_variant Exon 46 of 46 5 ENSP00000490223.1 A0A1B0GUS3
CACNA1AENST00000637736.1 linkc.7293C>T p.Tyr2431Tyr synonymous_variant Exon 46 of 46 5 ENSP00000489861.1 A0A1B0GTW2
CACNA1AENST00000636768.2 linkn.*1692C>T non_coding_transcript_exon_variant Exon 45 of 45 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.*2610C>T non_coding_transcript_exon_variant Exon 47 of 47 ENSP00000519091.1
CACNA1AENST00000636389.1 linkc.*517C>T 3_prime_UTR_variant Exon 47 of 47 5 ENSP00000489992.1 A0A1B0GU74
CACNA1AENST00000637432.1 linkc.*643C>T 3_prime_UTR_variant Exon 48 of 48 5 ENSP00000490617.1 O00555-2
CACNA1AENST00000635895.1 linkc.*643C>T 3_prime_UTR_variant Exon 47 of 47 5 ENSP00000490323.1 A0A384DVW2
CACNA1AENST00000638009.2 linkc.*643C>T 3_prime_UTR_variant Exon 47 of 47 1 ENSP00000489913.1 O00555-3
CACNA1AENST00000636768.2 linkn.*1692C>T 3_prime_UTR_variant Exon 45 of 45 5 ENSP00000490190.2 A0A1B0GUP3
CACNA1AENST00000713789.1 linkn.*2610C>T 3_prime_UTR_variant Exon 47 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
AF:
0.00734
AC:
1113
AN:
151570
Hom.:
10
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00182
Gnomad AMI
AF:
0.0399
Gnomad AMR
AF:
0.0201
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00934
Gnomad SAS
AF:
0.00994
Gnomad FIN
AF:
0.00619
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00757
Gnomad OTH
AF:
0.00961
GnomAD2 exomes
AF:
0.0126
AC:
1749
AN:
139132
AF XY:
0.0116
show subpopulations
Gnomad AFR exome
AF:
0.00133
Gnomad AMR exome
AF:
0.0327
Gnomad ASJ exome
AF:
0.000122
Gnomad EAS exome
AF:
0.0144
Gnomad FIN exome
AF:
0.00760
Gnomad NFE exome
AF:
0.00749
Gnomad OTH exome
AF:
0.0118
GnomAD4 exome
AF:
0.00852
AC:
11793
AN:
1384276
Hom.:
103
Cov.:
30
AF XY:
0.00864
AC XY:
5916
AN XY:
685000
show subpopulations
African (AFR)
AF:
0.00136
AC:
42
AN:
30914
American (AMR)
AF:
0.0312
AC:
1133
AN:
36344
Ashkenazi Jewish (ASJ)
AF:
0.000323
AC:
8
AN:
24778
East Asian (EAS)
AF:
0.0101
AC:
358
AN:
35486
South Asian (SAS)
AF:
0.0104
AC:
832
AN:
80028
European-Finnish (FIN)
AF:
0.00853
AC:
295
AN:
34598
Middle Eastern (MID)
AF:
0.00373
AC:
21
AN:
5632
European-Non Finnish (NFE)
AF:
0.00801
AC:
8641
AN:
1078958
Other (OTH)
AF:
0.00805
AC:
463
AN:
57538
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
632
1265
1897
2530
3162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
358
716
1074
1432
1790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00737
AC:
1118
AN:
151678
Hom.:
11
Cov.:
31
AF XY:
0.00782
AC XY:
580
AN XY:
74164
show subpopulations
African (AFR)
AF:
0.00179
AC:
74
AN:
41432
American (AMR)
AF:
0.0202
AC:
308
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3460
East Asian (EAS)
AF:
0.00937
AC:
48
AN:
5122
South Asian (SAS)
AF:
0.00974
AC:
47
AN:
4826
European-Finnish (FIN)
AF:
0.00619
AC:
65
AN:
10502
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00757
AC:
513
AN:
67794
Other (OTH)
AF:
0.0119
AC:
25
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00610
Hom.:
1
Bravo
AF:
0.00870

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 13, 2023
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
6.4
DANN
Benign
0.97
PhyloP100
0.15
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16059; hg19: chr19-13318217; API